Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-α and IFN-γ

Immunobiology

Volumn 200, Issue 1, 1999, Pages 1-20

  Borowski, Alexander ^a   Van Valen, Frans ^b   Ulbrecht, Matthias ^c   Weiss, Elisabeth H ^c   Blasczyk, Rainer ^d   Jürgens, Heribert ^b   Göbel, Ulrich ^a   Schneider, E Marion ^a,e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL LYSATE; EWING SARCOMA; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR WEIGHT; ONCOGENE C MYC; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STAINING; TUMOR CELL LINE;

EID: 0032994419     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(99)80029-1     Document Type: Article

References (65)

1. JüRGENS, H. F. 1994. Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Curr. Opin. Oncol. 6: 391.
2. AURIAS, A., C. RIMBAUT, D. BUFFE, J. DUBOUSSET, and A. MAZABRAUD. 1983. Chromosomal translocations in Ewings sarcoma. N. Engl. J. Med. 309: 496.
3. TURC-CAREL, C., I. PHILIP, M. P. BERGER, T. PHILIP, and C. M. LEMOIR. 1984. Chromosome study of Ewing's sarcoma (ES) cell lines: consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Gen. Cytogen. 12: 1.
4. DONNER, L. R. 1991. Cytogenetics and molecular biology of small round cell tumors and related neoplasms: current status. Cancer Gen. Cytogen. 54: 1.
5. DELATTRE, O., J. ZUCMAN, B. PLOUGASTEL, C. DESMAZE, T. MELOT, M. PETER, H. KOVAR, J. JOUBERT, P. DE JONG, G. ROULEAU, A. AURIAS, and G. THOMAS. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359: 162.
6. MAY, W. A., S. L. LESSNICK, B. S. BRAUN, M. KLEMSZ, B. C. LEWIS, L. B. LUNSFORD, R. HROMAS, and C. T. DENNY. 1993. The Ewing's sarcoma EWS/Fli-1 fusion gene encodes a more potent transcriptional activator and is more powerful transforming gene than FLI-1. Mol. Cell Biol. 13: 7393.
7. BAILLY, R.-A., R. BOSSELUT, J. ZUCMAN, F. CORMIER, O. DELATTRE, M. ROUSSEL, F. THOMAS, and J. GHYSDAEL. 1994. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell Biol. 14: 3230.
8. SHI, L. R., D. EICHELBAUER, F. BORCHARD, H. JÜRGENS, U. GÖBEL, and E. M. SCHNEIDER. 1994. Specificity and function of monoclonal antibodies directed against Ewing's sarcoma cells. Cancer Immunol. Immunother. 38. 208
9. HARA, S., E. ISHII, S. TANAKA, J. YOKOYMAMA, K. KATSUMATA, J. FUJIMOTO, and H. HATA. 1989. A monoclonal antibody specifically reactive with Ewing's sarcoma. Brit. J. Cancer 60: 873.
10. BOON, T., J.-C. CERROTTINI, B. VAN DEN EYNDE, P. VAN DER BRUGGEN, and A. VAN PEL. 1994. Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol. 12: 337.
11. SHAMAMIAN, P., M. MANCINI, Y. KAWAKAMI, N. P. RESTIFO, S. A. ROSENBERG, and S. L. TOPLIANI. 1994. Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest. Cancxer Immunol. Immunother. 39: 73.
12. SHAWAR, S. M., J. M. VYAS, J. R. RODGERS, and R. R. RICH. 1994. Antigen presentation by major histocompability complex class I-B molecules. Annu. Rev. Immunol. 12: 839.
13. PLOEGH, H. L., T. H. ORR, and J. L. STROMINGER. 1981. Major histocompability antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell 24: 287.
14. BIJLMAKERS, M. J., and H. L. PLOEGH. 1993. Putting together a MHC class I molecule. Curr. Opin. Immunol. 5: 21.
15. BJORKMAN, P. J., M. A. SAPER, B. SAMRAOUI, W. S. BENNET, J. L. STROMINGER, and D. C. WILEY. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompability antigens. Nature 329: 512.
16. HUANG, A, Y. C., A. T. BRUCE, D. M. PARDOLL, and H. I. LEVITSKY. 1996. In vivo crosspriming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4: 349.
17. GARRIDO, F., T. CABREARY, A. CONCHA, S. GLEW, F. RUIZ-CABELLO, and P. J. STERN. 1993. Natural history of HLA expression during tumour development. Immunol. Today 14: 491.
18. VAN VALEN, F., H. HANENBERG, C. FRIED, U. BOTT, S. BURDACH, W. WINKELMANN, J. JÜRGENS, and U. GÖBEL. Interferon-γ and tumor necrosis factor-α induce adhesion molecule ICAM-1 and HLA-class I antigen expression in Ewing sarcoma cells. Med. Ped. Oncology 19, 342, 23rd Meeting SIOP, Thodes, October 1-4, 1991.
19. VAN VALEN, F., W. WINKELMANN, and H. JÜRGENS. 1992. Type I and Type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells. J. Cancer Res. Clin. Oncol. 118: 269.
20. AMBROS, I. M., P. F. AMBROS, S. STREHL, H. KOVAR, H. GADNER, and M. SALZER-KUNTSCHIK. 1991. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67: 1886.
21. DOCKHORN-DWORNICZAK, B., K.-L. SCHÄFER, R. DANTCHEVA, S. BLASIUS, W. WINKELMANN, S. STREHL, S. BURDACH, F. VAN VALEN, H. JÜRGENS, and W. BÖCKER. 1994. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Virchows Archiv 425: 107.
22. 2-microglobulin associated with a human cell surface antigen. Nature 279: 243.
23. MÜLLER, C., A. ZIEGLER, G. MÜLLER, F. SCHUNTER, and P. WERNERT. 1982. Monoclonal antibody (Tü48) defining alloantigenic class I determinants specific for HLA-Bw4 and HLA-Aw23, Aw24, as well as Aw32. Hum. Immunol. 5: 296.
24. MÜLLER, C., L. SHI, E. M. SCHNEIDER, A. ZIEGLER, and P. WERNET. 1983. A cytotoxic monoclonal IgM antibody (Tü101) directed against an antigenic determinant shared between HLA-A allospecifities A2 and A28. Hum. Immunol. 6: 189.
25. HARPRECHT,. J., E. WESTPHAL, and W. MÜLLER-RUCHHOLTZ. 1988. Production and application of new monoclonal antibodies against HLA-A and -B antigens. Diagn. Clin. Immunol. 5: 388.
26. MOMBURG, F., A. ZIEGLER, J. HARPPRECHT, J. HARPRECHT, P. MÄLLER, G. MOLDENHAUER, and G. J. HÄMMERLING. 1989. Selective loss of HLA-A or HLA-B expression in colon carcinoma. J. Immunol. 142: 352.
27. LEON, J. A., R. MESA-TEJADA, and J. C. GUTIERREZ. 1991. Increased surface expression and shedding of tumor associated antigens by humanbreast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Anticancer Research 9: 1639.
28. YANG, S. Y. 1989. A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis. Immunobiology of HLA, Springer-Verlag, Volum I, p. 332.
29. ADAMS, L. D., and S. R. GALLAGHER. 1993. Electrophoretic separation of proteins. Current Protocols in Immunology, John Wiley & Sons, New York, pp 8.4.1.-8.4.21.
30. 2-microglobulin differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18: 801.
31. STAM, N.J., H. SPITS, and H. L. PLOEGH. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterisation of certain HLA-C products. J. Immunol. 137: 2299.
32. CHOMZYNSKI, P., and N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
33. ULBRECHT, M., T. HONKA, S. PERSON, J. P. JOHNSON, and E. H. WEISS. 1992. The HLA-E gene encodes two differentially regulated transcripts and cell surface protein. J. Immunol. 149: 2945.
34. COLLINS, M. L., and W. R. HUNSAKER. 1985. Improved hybridization assays employing tailed oligonucleotide probes: a direct comparison with 5′ end labeled oligonucleotide probes and nick-translated plasmid probes. Anal. Biochem. 151: 211.
35. SZÖTS, H., G. RIETHMÜLLER, E. H. WEISS, and T. MEO. 1986. Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B and -C allelic series. Proc. Natl. Acad. Sci. USA 83: 1428.
36. ULBRECHT, M., B. REHBERGER, I. STROBEL, G. MESSER, P. KIND, K. DEGITZ, T. BIEBER, E. H. WEISS. 1994. HLA-G: expression in human keratinocytes in vitro and in human skin in vivo. Eur. J. Immunol. 24: 176.
37. FEINBERG, A. P., and B. VOGELSTEIN. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6.
38. CHURCH, G. M., and W. GILBERT. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81: 1991.
39. TOWNSEND, A., and H. A. BODMER. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7: 601.
40. ELLIOT, B. E., D. A. CARLOW, A. M. RODRICKS, and A. WADE. 1989. Perspectives on the roles of MHC antigens in normal and malignant cell development. Adv. Cancer Res. 53: 181.
41. REBAI, N., B. MALISSEN. 1983. Structural and genetic analyses of HLA-class I molecules using monoclonal xenoantibodies. Tissue Antigens 22: 107.
42. SHIMIZU, Y., D. E. GERAGHTY, B. H. KOLLER, H. T. ORR, and R. DEMARS. 1988. Transfer and expression of three cloned human non-HLA-A, B, C class I major histocompability complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85: 227.
43. ULBRECHT, M., J. KELLERMANN, J. P. JOHNSON, and E. WEISS. 1992. Impaird intracellular transport and cell surface expression of nonpolymorphic HLA-E: Evidence for inefficient peptide binding. J. Exp. Med. 176: 1083.
44. HOULIHAN, J. M., P. A. BIRO, A. FERGAR-PAYNE, K. L. SIMPSON, and C. H. Holmes. 1992. Evidence for the expression of non-HLA-A, -B, -C class I genes in the human fetal liver. J. Immunol. 149: 668.
45. ISHITANI, A., and D. E. GERAGHTY. 1992. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II molecules. Proc. Natl. Acad. Sci. USA 89: 3947.
46. SARGENT, I. L. 1993. Maternal and fetal immune responses during pregnancy. Exp. Clin. Immunogenet. 10: 85.
47. SCHMIDT, C. M., and H. T. ORR. 1993. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G. Grit. Rev. immunol. 13: 207.
48. FUJI, T., A. ISHITANI, and D. E. GERAGHTY. 1994. An incompletely spliced message encodes a soluble form of HLA-G. J. Immunol. 153: 5516.
49. DAVID-WATINE, B., A. ISRAEL, and P. KOURILSKY. 1990. The regulation and expression of MHC class I genes. Immunol. Today 8: 286.
50. SINGER, D. S., and J. E. MAGUIRE. 1990. Regulation of the expression of class I MHC genes. Crit. Rev. Immunol. 10: 235.
51. GERAGHTY, D. E., B. H. KOLLER, and H. T. ORR. 1987. A human major histocompability complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc. Natl. Acad. Sci. USA 84: 9145.
52. TIBENSKY, D., and T. DELOVITCH. 1990. Promoter region of HLA-C genes: regulatory elements common to and different from those of HLA-A and HLA-B genes. Immunogen. 32: 210.
53. JOHNSON, D. R., and J. S. POBER. 1994. HLA-class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell Biol. 14: 1322.
54. JOHNSON, D. R., and J. S. POBER. 1990. Tumor necrosis factor and immune interferon synergistically increase transcription of HLA-class I heavy- and light-chain genes in vascular endothelium. Proc. Natl. Acad. Sci. USA 87: 5183.
55. MCCUTCHEON, J. A., J. GUPERZ, K. D. SMITH, C. T. LUTZ, and P. PARHAM. 1995. Low HLA-C expression at cell surface correlates with increased turnover of heavy chein mRNA. J. Exp. Med. 181: 2085.
56. WEI, X., and H. T. ORR. 1990. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissues. Hum. Immunol 29: 131.
57. HOULIHAN, J. M., P. A. BIRD, H. M. HARPER, H. J. JENKINSON, and C. H. HOLMES. 1995. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J. Immunol 154: 5665.
58. GARRIDO, F., T. CABRERA, M. A. LOPEZ-NEVOT, and F. RUIZ-CABELLO. 1996. HLA-class I antigens in human tumors. Adv. Cancer Res. 64: 155.
59. HOROWITZ, M. E., T. F. DELANEY, M. M. MALAWER, and M. G. TSOKOS. 1993. Ewing's sarcoma family tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neurectodermal tumors. P. A. PIZZO; D. G. POPLACK. Principles and practice of pediatric oncology, Ed. 2, Philadelphia: J. B. Lippincott, pp 795.
60. OZATO, K., J. WAN, and B. ORRISON. 1985. Mouse major histocompability class I gene expression begins at midsomite stage and is inducible in earlierstage embryos by interferon. Proc. Natl. Acad. Sci. USA 82: 2427.
61. RINKE DE WIT, T. F., S. VLOEMANS, P. J. VAN DEN ELSEN, A. HAWORTH, and P. L. STERN. 1990. Differential expression of the HLA-class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. J. Immunol. 144: 1080.
62. SCHRIER, P. I., and L. T. C. PELTENBURG. 1993. Relationship between myc oncogene activation and MHC class I expression. Adv. Cancer Res. 60: 181.
63. ZOUBEK, A:, B. DOCKHORN-DWORNICZAK, O. DELATTRE, H. CHRISTIANSEN, F. NIGGLI, I. GATTERER-MENZ, T. L. SMITH, H. JÜRGENS, H. GADNER, and H. KOVAR. 1996. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing Tumor patients? J. Clin. Oncology 14: 1245.
64. HEEMELS, M.-T., and H. L. PLOEGH. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annul. Rev. Biochem. 64: 463.
65. CROMME, F. V., J. AIREY, M. T. HEEMELS, H. L. PLOEGH, P. J. KEATING, P. L. STERN, C. J. L. M. MEIJER, and J. M. M. WALBOOMERS. 1994. Loss or transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinoma. J. Exp. Med. 179: 335.